Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Herman

Showing results (911-920 of 972) with videos related to

Pageof 98
Sort By:
Biorxiv : the Preprint Server for Biology|April 16, 2025
TARP ɣ-8 is a target of ethanol that regulates self-administration and relapse in miceSara Faccidomo, Jessica L Hoffman, Julie Lee, et al.
Cell|October 11, 2014
Discovery of a class of endogenous mammalian lipids with anti-diabetic and anti-inflammatory effectsMark M Yore, Ismail Syed, Pedro M Moraes-Vieira, et al.
Clinical Therapeutics|February 24, 2006
Pharmacokinetic and pharmacodynamic properties of multiple oral doses of sitagliptin, a dipeptidyl peptidase-IV inhibitor: a double-blind, randomized, placebo-controlled study in healthy male volunteersArthur J Bergman, Catherine Stevens, YanYan Zhou, et al.
Clinical Pharmacology and Therapeutics|December 13, 2005
Pharmacokinetics and pharmacodynamics of sitagliptin, an inhibitor of dipeptidyl peptidase IV, in healthy subjects: results from two randomized, double-blind, placebo-controlled studies with single oral dosesGary A Herman, Cathy Stevens, Kristien Van Dyck, et al.
Journal of Cachexia, Sarcopenia and Muscle|April 9, 2011
Evaluation of early biomarkers of muscle anabolic response to testosteroneFabian Chen, Raymond Lam, David Shaywitz, et al.
Nature Communications|May 13, 2025
GDF8 and activin A are the key negative regulators of muscle mass in postmenopausal females: a randomized phase I trialDinko Gonzalez Trotter, Stephen Donahue, Chris Wynne, et al.
Regulatory Toxicology and Pharmacology : RTP|April 24, 2016
Assessment of potential adjuvanticity of Cry proteinsSaurabh S Joshi, Brian Barnett, Nancy G Doerrer, et al.
Neuroimage|September 3, 2021
An isotropic EPI database and analytical pipelines for rat brain resting-state fMRISung-Ho Lee, Margaret A Broadwater, Woomi Ban, et al.
Bioscience, Biotechnology, and Biochemistry|July 12, 2016
Inter-laboratory optimization of protein extraction, separation, and fluorescent detection of endogenous rice allergensRie Satoh, Reiko Teshima, Kazumi Kitta, et al.
Open Forum Infectious Diseases|May 25, 2023
Effectiveness of Casirivimab and Imdevimab Antibody Combination in Immunocompromised Hospitalized Patients With Coronavirus Disease 2019: A Post Hoc Analysis in a Phase 1/2/3 Double-Blind TrialSelin Somersan-Karakaya, Eleftherios Mylonakis, Jenni Mou, et al.
Pageof 98

Showing results (911-920 of 972) with videos related to

Sort By:
Pageof 98
Biorxiv : the Preprint Server for Biology|April 16, 2025
TARP ɣ-8 is a target of ethanol that regulates self-administration and relapse in miceSara Faccidomo, Jessica L Hoffman, Julie Lee, et al.
Cell|October 11, 2014
Discovery of a class of endogenous mammalian lipids with anti-diabetic and anti-inflammatory effectsMark M Yore, Ismail Syed, Pedro M Moraes-Vieira, et al.
Clinical Therapeutics|February 24, 2006
Pharmacokinetic and pharmacodynamic properties of multiple oral doses of sitagliptin, a dipeptidyl peptidase-IV inhibitor: a double-blind, randomized, placebo-controlled study in healthy male volunteersArthur J Bergman, Catherine Stevens, YanYan Zhou, et al.
Clinical Pharmacology and Therapeutics|December 13, 2005
Pharmacokinetics and pharmacodynamics of sitagliptin, an inhibitor of dipeptidyl peptidase IV, in healthy subjects: results from two randomized, double-blind, placebo-controlled studies with single oral dosesGary A Herman, Cathy Stevens, Kristien Van Dyck, et al.
Journal of Cachexia, Sarcopenia and Muscle|April 9, 2011
Evaluation of early biomarkers of muscle anabolic response to testosteroneFabian Chen, Raymond Lam, David Shaywitz, et al.
Nature Communications|May 13, 2025
GDF8 and activin A are the key negative regulators of muscle mass in postmenopausal females: a randomized phase I trialDinko Gonzalez Trotter, Stephen Donahue, Chris Wynne, et al.
Regulatory Toxicology and Pharmacology : RTP|April 24, 2016
Assessment of potential adjuvanticity of Cry proteinsSaurabh S Joshi, Brian Barnett, Nancy G Doerrer, et al.
Neuroimage|September 3, 2021
An isotropic EPI database and analytical pipelines for rat brain resting-state fMRISung-Ho Lee, Margaret A Broadwater, Woomi Ban, et al.
Bioscience, Biotechnology, and Biochemistry|July 12, 2016
Inter-laboratory optimization of protein extraction, separation, and fluorescent detection of endogenous rice allergensRie Satoh, Reiko Teshima, Kazumi Kitta, et al.
Open Forum Infectious Diseases|May 25, 2023
Effectiveness of Casirivimab and Imdevimab Antibody Combination in Immunocompromised Hospitalized Patients With Coronavirus Disease 2019: A Post Hoc Analysis in a Phase 1/2/3 Double-Blind TrialSelin Somersan-Karakaya, Eleftherios Mylonakis, Jenni Mou, et al.
Pageof 98